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The relationships of Sr intestinal absorption and renal
excretion with biohumoral factors regulating Ca metab-
olism were studied in 47 normocalciuric subjects with
Ca kidney stones. Sr concentrations were measured in
serum and urine after an oral load of stable Sr (30.2
mmol/kg body wt). Enteral absorption of the ion (9.77 6
0.438 mmol z L21 z min, 240 min after Sr administration),
expressed as the area under the plasma concentration–
time curve (AUC), and renal clearance (CRE) in these
subjects during the test (2.80 6 0.336 mL/min) were not
different from values for 27 controls. CRE was not
correlated with AUCs. Plasma concentrations of para-
thyroid hormone (PTH) negatively correlated with
AUCs (P <0.01) and correlated with CRE after one
outlier was excluded (P <0.05). Plasma concentrations of
1,25-dihydroxyvitamin D correlated positively with
AUCs (P <0.01) when normalized to the plasma concen-
tration of PTH. Multiple stepwise regression showed
that PTH and phosphatemia were significantly related
to AUC values at 240 min (P <0.01). These findings
suggest that Sr absorption and excretion reflect the
regulation of Ca metabolism, but some differences in
renal handling of the two ions may exist.
Strontium is a bivalent ion, present in human fluids as a
trace element and taking no part in the biological cycle [1, 2].
The transport of Sr ions through enteral and renal tubular
cells is mediated by the same membrane carriers as used for
calcium, and a highly significant correlation has been ob-
served between Sr and Ca absorption [2–6]. Therefore, the
oral administration of stable Sr is considered suitable for
assessing Ca absorption and excretion in clinical practice
[1, 3, 7–10]. According to the proposed tests, stable Sr is
administered orally and ion concentrations are determined
in serum 240 min after the oral load. Results of the absorp-
tion test at 240 min are the most representative of Sr
bioavailability [10], whereas those obtained during the first
hour depend more on duodenal and jejunal absorption
efficiency [1, 9]. Studies comparing Sr and Ca handling in
humans showed that Sr ions are less absorbed in intestine
than Ca, but are more quickly excreted in urine and in
enteral lumen with digestive secretions [4–6]. These find-
ings could be attributed to a lower cellular carrier affinity for
Sr, which favors Ca transport to blood [11, 12]. Renal clear-
ance represents 50–60% of the total body ion clearance [13];
its values show that Sr ions are extensively reabsorbed by
the renal tubule [1–6].
The biohumoral factors regulating Sr handling have not
been extensively investigated, although they are generally
assumed to be similar to those regulating Ca metabolism.
The available data show that Sr absorption is increased by
therapeutic administration of 1,25-dihydroxyvitamin D or
renal activation of 25-hydroxyvitamin D-1a-hydroxylase
[14, 15]. To investigate biohumoral factors regulating Sr
handling, we analyzed the relationships of Sr absorption
and renal clearance with the indices of Ca metabolism in a
group of normocalciuric subjects with idiopathic Ca neph-
rolithiasis and normal kidney function. In these subjects,
plasma and urine concentrations of Ca and phosphate were
within the respective reference intervals, as were their secre-
tions of calciotropic hormones [16, 17].
Subjects and Methods
subjects
Forty-seven normocalciuric patients (29 men and 18
women, weights 69.7 6 1.67 kg, ages 44 6 2.0 years) with
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Ca-oxalate nephrolithiasis participated in the study. They
were free of other diseases, and their 24-h Ca excretion
was ,7.5 mmol in the men or ,6.25 mmol in the women
and ,0.1 mmol/kg of body weight for both sexes; their
plasma Ca and creatinine concentrations were within the
respective reference intervals. All patients consumed
dairy products in their diet and took ;25 mmol of Ca per
day. None took drugs. Four women were postmeno-
pausal (ages 56–65 years). The Sr absorption test was also
carried out in 27 age- and sex-matched healthy volunteers
(ages 40 6 2.1 years, 15 men and 12 women, 3 of whom
were postmenopausal). None of the patients or controls
had voiding difficulties.
All gave informed consent to the study, which was
approved by San Raffaele’s Hospital Ethical Committee.
experimental protocol
A Sr oral load test was performed after overnight fasting.
Sr was administered to patients at 30.2 mmol/kg body wt
(2.65 mg/kg), in water solution [11.4 mmol/L (1 g/L)] as
the chloride salt (obtained from BDH). Blood samples
were drawn before and at 30, 60, and 240 min after Sr
administration. Urine was also collected during the test.
Within-subject reproducibility of plasma Sr, including
analytical and biological variability, had been previously
calculated as the CV [18]:
CV~%! 5 100 z
Î 12nO~xi 2 yi)2
O(xi 1 yi)
2n
(1)
where xi and yi are the values of the repeated measure-
ments in the ith subject and n is the number of subjects.
The CV for the area under the concentration–time curve
(AUC)5 was 20.6%, 20.0%, and 11.8%, respectively, after
30, 60, and 240 min in 15 subjects who submitted to the
test twice. The CV of Sr urine excretion was calculated in
6 subjects and was 33.4%.
assays
Calcium, phosphate, creatinine, and sodium were mea-
sured in plasma and 24-h urine. Intact parathyroid hor-
mone (PTH) and 1,25-dihydroxyvitamin D in plasma
were determined respectively by an IRMA and a radiore-
ceptor assay (both from Nichols Institute). 1,25-Dihy-
droxyvitamin D was determined in 36 of 47 patients.
The Sr concentration was measured by atomic absorp-
tion spectrophotometry at 460.7 nm (Perkin-Elmer 4000)
with use of an acetylene–air flame in 10-fold-diluted
serum and 50-fold-diluted urine with 20 g/L lanthanum
(BDH) and 100 mL/L hydrochloric acid as the diluent.
Bone mineral density (BMD) was assessed by dual-
energy x-ray absorptiometry (Hologic QDR 1000) in 37 of
the 47 stone formers (21 men and 16 women, 3 of whom
were postmenopausal) at three femoral sites (neck, tro-
chanter, Ward’s triangle) and the L1–L4 lumbar spine
vertebrae. The BMD values were expressed as the number
of standard deviations from the mean of a Caucasian
normal young population (t-score).
calculations
Strontium absorption was calculated as the incremental
(above baseline) serum AUC at 30, 60, and 240 min
(AUC30, AUC60, AUC240) determined by the trapezoid
method and expressed as mmol z L21 z min [14].
Renal excretion of Sr was quantified by assessing the
fraction of administered Sr excreted in the urine (FE) and
the Sr renal clearance (CRE). FE was calculated as follows:
FE(%) 5 (qE240/D) z 100 (2)
where qE240 is the amount of Sr (above baseline) measured
in the urine at the end of the test and D is the orally
administered dose of Sr. Because the urinary excretion is
the product of the renal clearance times the plasma
concentration, CRE was calculated as follows:
CRE(mL/min) 5 qE240/AUC240 (3)
statistical analysis
Data are expressed in the text as mean 6 SE. Statistical
difference between the mean values were analyzed by
Mann–Whitney’s U-test. Simple linear correlations be-
tween variables were tested. Multiple stepwise regression
was performed by assuming each of the AUC values as
the dependent variable and age, Ca excretion, PTH,
1,25-dihydroxyvitamin D, CRE, and plasma phosphate as
independent variables. Multiple stepwise regression was
also performed by assuming FE or CRE as the dependent
variable and age, Ca excretion, PTH, 1,25-dihydroxyvita-
min D, AUC240, and plasma phosphate as independent
variables.
Results
All the patients showed reference interval values for PTH
and electrolytes in plasma and urine (Table 1). BMD was
measured in 37 of 47 stone formers, and 9 results indi-
cated osteoporosis (t-score ,22.5, independent of mea-
surement site).
The profile of mean plasma Sr concentration during the
test is shown in Fig. 1: The values were greatest 240 min
after the oral Sr load. The values of Sr absorption and
renal excretion (Table 2) were not different from the
control values. No significant differences were found
between the men’s and women’s values: AUC240 was
10.56 6 0.644 mmol z L21zmin in women and 9.29 6 0.578
in men; CRE was 2.7 6 0.34 mL/min and 2.9 6 0.48,
respectively.
Neither AUCs, FE, nor CRE correlated with Ca or
5 Nonstandard abbreviations: AUC, area under the plasma Sr concentra-
tion–time curve; CRE, Sr renal clearance; FE, fractional urine excretion of the
administered Sr; BMD, bone mineral density; PTH, parathyroid hormone.
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phosphate excretions, Ca or phosphate plasma concentra-
tions, and lumbar or femoral BMD.
Table 3 reports the results of the correlation analysis
between the indices of Sr absorption, renal excretion, and
calciotropic hormones. Sr FE positively correlated with
AUC240, but not with AUC30 and AUC60. Sr CRE showed
no relation with absorption values. Plasma concentrations
of PTH correlated negatively with AUC30 (Fig. 2; upper
panel), AUC60, and AUC240, the correlation strength de-
creasing at 240 min. PTH values also correlated negatively
with Sr FE. The negative correlation between PTH and
CRE became significant when one outlier with very high
clearance was excluded (r 5 20.346, P ,0.05, n 5 46; Fig.
2, lower panel). Plasma concentrations of 1,25-dihy-
droxyvitamin D, measured in 36 patients, had no relation
with Sr AUCs and excretion; when normalized to the
concentration of plasma PTH (picograms of 1,25-dihy-
droxyvitamin D per picogram of PTH), however, they
correlated positively with AUC30 (r 5 0.425, P ,0.01) and
AUC60 (r 5 0.388, P ,0.05).
Multiple stepwise regression showed that PTH was the
only analyte significantly related to AUC30, AUC60, CRE,
and FE, whereas PTH and plasma phosphate were signif-
icantly related to AUC240 (cumulative r
2 5 0.274, P ,0.01).
Discussion
Strontium absorption and excretion were measured in a
group of normocalciuric subjects with Ca kidney stones
by an oral load of stable Sr. The Ca metabolism of these
subjects was comparable with that of normal subjects
[16, 17]. Accordingly, the values of Sr absorption and
renal excretion obtained in our population were similar to
those found or previously reported in healthy subjects
[1, 3, 7–11]. We saw no clear influence of gender on Sr
absorption; a lower body water content could sustain the
slightly higher values of women in comparison with those
in men.
We measured 4-h Sr excretion after an oral load to
estimate the renal Sr clearance [1–3]. Renal clearance
represents 50–60% of total body Sr clearance [1–6, 13, 19];
the other part of ion clearance is predominantly carried
out by bone and digestive secretions, which become
Table 1. Divalent ion metabolism indices in 47
normocalciuric stone formers.
Ref. value
Mean 6 SE
measured in stone
formers
Plasma
Calcium, mmol/L 2.1–2.6 2.37 6 0.011
Phosphate, mmol/L 0.8–1.55 1.13 6 0.027
Parathyroid hormone,
ng/L
10–65 33.6 6 2.07
1,25-Dihydroxyvitamin
D, ng/La
25–70 47.8 6 3.01
Urine
Creatinine clearance,
mL/min
70–140 91 6 4.4
Calcium, mmol/24 h M, 2–7.5
F, 1.8–6.25
Both sexes, ,0.1
mmol/kg bwc
4.41 6 0.168
Phosphate, mmol/24 h 10–35 26.28 6 1.123
Sodium, mmol/24 h 151 6 10.7
BMDb t-score
L1–L4 lumbar spine 21.18 6 0.171
Upper total femur 21.37 6 0.133
a 1,25-Dihydroxyvitamin D was measured in 36 patients.
b Measured in 37 patients, normal when t-score was .21.
c Body weight (bw) was 69.7 6 1.67 kg.
Fig. 1. Sr concentrations in serum measured 30, 60, and 240 min after
an oral load of 30.2 mmol/kg body wt (2.65 mg/kg body wt; see
Methods).
Table 2. Results of Sr oral load test.
Stone formers Controls
n 47 27
AUC30, mmol z L
21 z min 0.33 6 0.025 0.32 6 0.041
AUC60, mmol z L
21 z min 1.25 6 0.073 0.98 6 0.069
AUC240, mmol z L
21 z min 9.77 6 0.438 8.00 6 0.460
FE, % of administered Sr 1.3 6 0.14 1.5 6 0.61
CRE, mL/min 2.80 6 0.336 3.15 6 1.381
Results in controls and stone formers were not statistically different.
Table 3. Correlation between Sr absorption or excretion
indices and calciotropic hormones.
AUC30 AUC60 AUC240 FE CRE
FE 0.198 0.272 0.321a 0.788b
CRE 20.182 20.164 20.168 0.788
b
PTH 20.426b 20.419b 20.357a 20.447b 20.328a,c
1,25-(OH)2D 20.028 20.096 20.218 20.197 20.171
a P ,0.05; b P ,0.01.
c n 5 46: the significant correlation coefficient between CRE and parathyroid
hormone was obtained after exclusion of an outlier, as shown in Fig. 2 (lower
panel); when this patient was not excluded, the correlation was not significant
(n 5 47, r 5 20.225).
1,25-(OH)2D, 1,25-dihydroxyvitamin D.
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relevant later in the period of patient observation
[1–6, 13]. Our findings did not show any correlation
between renal Sr clearance and enteral absorption. Be-
cause Ca excretion is decreased by PTH activity on distal
tubular cells, a negative correlation between renal Sr
clearance and PTH plasma concentrations was expected,
as for Ca. Conversely, renal Sr clearance and PTH plasma
concentrations correlated weakly in our patients (r 5
20.328), but only when one subject with a very high
clearance value was excluded from the analysis. Difficulty
in finding a strong correlation could be attributed to an
imprecise estimate of Sr clearance, given the relative short
period of urine collection (4 h). In addition, some differ-
ences in Ca and Sr tubular handling cannot be excluded.
These ions could be reabsorbed by different mechanisms
or handled differently by the same carriers. Because of the
different carrier affinity, PTH stimulates Ca transport
more than it does Sr; therefore, PTH could increase
tubular discrimination between the ions [5, 6], and its
effect on Sr reabsorption could be too small to reveal a
strong correlation.
PTH was the variable most significantly linked to
enteral Sr absorption. The negative correlation between
these two provides evidence of the interplay between
parathyroid secretion and Ca absorption: Hormone secre-
tion is inhibited in the subjects with high Ca and Sr
absorption and stimulated when enteral ion absorption is
low [17]. The relation is more evident in the early phases
of absorption processes, when excretion, bone deposition,
and other metabolic factors scarcely influence the plasma
values of bivalent ions [2, 4–6, 13].
Stepwise regression indicated that plasma phosphate
variations significantly affect the last phases of Sr absorp-
tion during the test—in agreement with our knowledge
that plasma phosphate negatively influences 1,25-dihy-
droxyvitamin D synthesis and consequently the enteral
transport of Ca and Sr [14, 15, 20].
Although 1,25-dihydroxyvitamin D is well known to
increase Sr and Ca absorption [14, 15, 17], its plasma
concentrations do not correlate with either enteral absorp-
tion or urine excretion of Sr. Our results are similar to
those previously observed, which showed a lack of cor-
relation between 1,25-dihydroxyvitamin D and Ca ab-
sorption as assessed by radiocalcium in normal subjects
[21, 22]. These findings suggest that plasma concentra-
tions of 1,25-dihydroxyvitamin D may be insufficient
indices of the hormone biological activity, given the
complex interrelationships with the other variables [20–
23]. When these interrelationships are taken into account
by normalizing 1,25-dihydroxyvitamin D plasma values
to PTH concentrations, their cooperative role in enhanc-
ing absorption of bivalent ions emerges [23]. The normal-
ization to PTH was previously proposed as an index of
1,25-dihydroxyvitamin D production [24].
In conclusion, this study of a normocalciuric population
suggests that Sr absorption reflects the hormonal regula-
tion of Ca absorption. Some differences in renal handling
of the two ions are suggested by the weak correlation of
renal Sr clearance with PTH and by the lack of relation-
ship with Sr absorption and Ca excretion.
We thank Renato Spaventa for helpful criticism and
linguistic advice.
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